JP2014532063A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532063A5 JP2014532063A5 JP2014534918A JP2014534918A JP2014532063A5 JP 2014532063 A5 JP2014532063 A5 JP 2014532063A5 JP 2014534918 A JP2014534918 A JP 2014534918A JP 2014534918 A JP2014534918 A JP 2014534918A JP 2014532063 A5 JP2014532063 A5 JP 2014532063A5
- Authority
- JP
- Japan
- Prior art keywords
- enamide
- piperidin
- amino
- ethynylphenyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- -1 4-((3-ethynylphenyl) amino) -7-methoxyquinazolin-6-yl Chemical group 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- IMLBZWHQWRDARS-FMIVXFBMSA-N (E)-N-[7-ethoxy-4-(3-ethynylanilino)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide Chemical compound C=12C=C(NC(=O)\C=C\CN3CCCCC3)C(OCC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 IMLBZWHQWRDARS-FMIVXFBMSA-N 0.000 claims 1
- VZIHTQKMHLOIII-UHFFFAOYSA-N 3,5-dihydro-2H-furan Chemical group [CH]1CCOC1 VZIHTQKMHLOIII-UHFFFAOYSA-N 0.000 claims 1
- 102000030951 Phosphotransferases Human genes 0.000 claims 1
- 108091000081 Phosphotransferases Proteins 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 230000003463 hyperproliferative Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001105 regulatory Effects 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
Claims (8)
- 以下からなる群から選択される化合物またはその薬学的に許容される塩もしくはその溶媒和物:
(E)-N-(4-((3-エチニルフェニル)アミノ)-7-メトキシキナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド;
(E)-N-(7-エトキシ-4-((3-エチニルフェニル)アミノ)キナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド;
(E)-N-(4-((3-エチニルフェニル)アミノ)-7-(2-フルオロエトキシ)キナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド;
(E)-N-(4-((3-エチニル-4-フルオロフェニル)アミノ)-7-メトキシキナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド;
(E)-N-(4-((3-エチニルフェニル)アミノ)-7-((テトラヒドロフラン-3-イル)オキシ)キナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド;
(E)-N-(4-((3-エチニルフェニル)アミノ)-7-(2-メトキシエトキシ)キナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド;
(E)-N-(4-((3-エチニルフェニル)アミノ)-7-d3-メトキシキナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド;および
(E)-N-(7-d5-エトキシ-4-((3-エチニルフェニル)アミノ)キナゾリン-6-イル)-4-(ピペリジン-1-イル)ブタ-2-エンアミド。 - 請求項1または2に記載の化合物および薬学的に許容される担体を含む、医薬組成物。
- 医薬としての使用のための、請求項1または2に記載の化合物または請求項3に記載の医薬組成物。
- 過剰増殖障害の治療または予防のための、請求項1または2に記載の化合物または請求項3に記載の医薬組成物の使用。
- キナーゼシグナル伝達を制御するための、請求項1または2に記載の化合物の使用。
- 新形成を治療するための、請求項1または2に記載の化合物の使用。
- 新形成を治療するための1つまたは複数の抗癌剤と組み合わせた、請求項1または2に記載の化合物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161627359P | 2011-10-12 | 2011-10-12 | |
US61/627,359 | 2011-10-12 | ||
PCT/CN2012/001371 WO2013053206A1 (en) | 2011-10-12 | 2012-10-12 | Quinazoline derivatives as kinases inhibitors and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014532063A JP2014532063A (ja) | 2014-12-04 |
JP2014532063A5 true JP2014532063A5 (ja) | 2015-12-03 |
Family
ID=48081378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014534918A Pending JP2014532063A (ja) | 2011-10-12 | 2012-10-12 | キナーゼ阻害剤としてのキナゾリン誘導体およびその使用方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9388160B2 (ja) |
EP (1) | EP2766356B1 (ja) |
JP (1) | JP2014532063A (ja) |
KR (1) | KR20140093223A (ja) |
CN (1) | CN103874696B (ja) |
WO (1) | WO2013053206A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104736155B (zh) | 2012-05-14 | 2018-01-02 | 杭州德润玉成生物科技有限公司 | 双环化合物作为激酶的抑制剂 |
WO2014177038A1 (en) | 2013-04-28 | 2014-11-06 | Sunshine Lake Pharma Co., Ltd. | Aminoquinazoline derivatives and their salts and methods of use thereof |
CN105705493B (zh) | 2014-08-15 | 2017-11-28 | 安润医药科技(苏州)有限公司 | 喹唑啉衍生物、其制备方法、药物组合物和应用 |
CN108779079A (zh) * | 2016-01-06 | 2018-11-09 | 特里乌姆治疗公司 | 作为egfr抑制剂的新的氟化喹唑啉衍生物 |
CA3096304A1 (en) * | 2018-06-14 | 2019-12-19 | Dana-Farber Cancer Institute, Inc. | Cyano quinoline amide compounds as her2 inhibitors and methods of use |
KR102260995B1 (ko) * | 2018-11-28 | 2021-06-04 | 국립암센터 | Plk1의 활성 억제제를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2280375T3 (es) | 2000-04-08 | 2007-09-16 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparacion. |
US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
DE10217689A1 (de) * | 2002-04-19 | 2003-11-13 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
US20040044014A1 (en) | 2002-04-19 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
PE20040945A1 (es) | 2003-02-05 | 2004-12-14 | Warner Lambert Co | Preparacion de quinazolinas substituidas |
US7223749B2 (en) * | 2003-02-20 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
DE10307165A1 (de) * | 2003-02-20 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
GEP20084551B (en) | 2004-05-06 | 2008-11-25 | Warner Lambert Co | 4-phenylamino-quinazolin-6-yl-amides |
US7905352B2 (en) * | 2004-12-06 | 2011-03-15 | Washington Biotech Corporation | Kits containing medicine injection devices and containers |
DE102005030733A1 (de) * | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff |
CN101100466B (zh) * | 2006-07-05 | 2013-12-25 | 天津和美生物技术有限公司 | 不可逆蛋白质酪氨酸磷酰化酶抑制剂及其制备和应用 |
US8198301B2 (en) | 2006-07-05 | 2012-06-12 | Hesheng Zhang | Quinazoline and quinoline derivatives as irreversibe protein tyrosine kinase inhibitors |
AU2008347940A1 (en) * | 2008-01-18 | 2009-07-23 | Natco Pharma Limited | 6,7-dialkoxy quinazoline derivatives useful for treatment of cancer related disorders |
JP2015515995A (ja) * | 2012-05-07 | 2015-06-04 | テリジェン リミテッドTeligene Ltd | キナーゼ阻害剤として有用な置換アミノキナゾリン |
-
2012
- 2012-10-12 JP JP2014534918A patent/JP2014532063A/ja active Pending
- 2012-10-12 KR KR1020147011460A patent/KR20140093223A/ko not_active Application Discontinuation
- 2012-10-12 CN CN201280049954.0A patent/CN103874696B/zh active Active
- 2012-10-12 WO PCT/CN2012/001371 patent/WO2013053206A1/en active Application Filing
- 2012-10-12 EP EP12839322.0A patent/EP2766356B1/en not_active Not-in-force
- 2012-10-12 US US14/351,557 patent/US9388160B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2017127135A (ru) | Терапевтическое средство против рака желчных протоков | |
JP2014532063A5 (ja) | ||
JP2016528301A5 (ja) | ||
MA38380A1 (fr) | Inhibiteurs quinazoline de l'activation des formes mutantes du récepteur de croissance épidermique (egfr) | |
WO2012028332A8 (en) | Pharmaceutically active compounds as axl inhibitors | |
JP2017514910A5 (ja) | ||
JP2017533968A5 (ja) | ||
JP2015514808A5 (ja) | ||
JP2013542256A5 (ja) | ||
MX2013012776A (es) | Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina. | |
MX336051B (es) | Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa. | |
JP2014511892A5 (ja) | ||
PH12015500457A1 (en) | Alkoxy pyrazoles as soluble guanylate cyclase activators | |
WO2014031438A3 (en) | SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS | |
RU2014135436A (ru) | Комбинация ингибитора rtk с антиэстрогеном и ее применение для лечения рака | |
RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
WO2007065662A3 (en) | Trisubstituted quinazolinone derivatives as vanilloid antagonists | |
RU2018113718A (ru) | Новые соединения | |
JP2013542261A5 (ja) | ||
TN2012000110A1 (en) | N-4 ( - ( ( 3- ( 2 -amino-4 pyrimidinyl) -2 -pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer | |
PH12015501945A1 (en) | Formulations of organic compounds | |
WO2014014794A3 (en) | Mineralocorticoid receptor antagonists | |
EA201791881A1 (ru) | Производные 2-аминопиридина в качестве антагонистов рецептора аденозина aи лигандов рецепторов мелатонина mt | |
RU2015101702A (ru) | Фармацевтически активные соединения | |
AU2017254345A1 (en) | Novel Crystalline salt forms of 3-(1,2,4-Triazolo(4,3-a)Pyridine-3-Ylethynyl)-4-Methyl-n-(4-((4-Methylpiperazin-1-yl)Methyl)-3-Trifluoromethylphenyl)Benzamide for medical application |